Glycosphingolipids (GSLs) are a group of membrane components that contain lipid and sugar moieties. They are present in essentially all animal cells and are believed to have important roles in various cellular processes. UDP-glucose ceramide glucosyltransferase catalyzes the first glycosylation step in glycosphingolipid biosynthesis. The product, glucosylceramide, is the core structure of more than 300 GSLs. UGCG is widely expressed and transcription is upregulated during keratinocyte differentiation.
^Ichikawa S, Ozawa K, Hirabayashi Y (Jun 1998). "Assignment of a UDP-glucose:ceramide glucosyltransferase gene (UGCG) to human chromosome band 9q31 by in situ hybridization". Cytogenet Cell Genet79 (3–4): 233–4. doi:10.1159/000134731. PMID9605861.
Ichikawa S, Sakiyama H, Suzuki G, et al. (1996). "Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis". Proc. Natl. Acad. Sci. U.S.A.93 (22): 12654. doi:10.1073/pnas.93.22.12654. PMC38048. PMID8901638.
Watanabe R, Wu K, Paul P, et al. (1998). "Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation". J. Biol. Chem.273 (16): 9651–5. doi:10.1074/jbc.273.16.9651. PMID9545298.
Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000). "Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens". J. Biol. Chem.275 (44): 34810–7. doi:10.1074/jbc.M005142200. PMID10945987.
Ogretmen B, Schady D, Usta J, et al. (2001). "Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells". J. Biol. Chem.276 (27): 24901–10. doi:10.1074/jbc.M100314200. PMID11335714.
Di Sano F, Fazi B, Citro G, et al. (2003). "Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells". Cancer Res.63 (14): 3860–5. PMID12873973.
Grazide S, Terrisse AD, Lerouge S, et al. (2004). "Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines". J. Biol. Chem.279 (18): 18256–61. doi:10.1074/jbc.M314105200. PMID14766899.
Norris-Cervetto E, Callaghan R, Platt FM, et al. (2004). "Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells". J. Biol. Chem.279 (39): 40412–8. doi:10.1074/jbc.M404466200. PMID15263008.
Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res.14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC528928. PMID15489334.
Turzanski J, Grundy M, Shang S, et al. (2005). "P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway". Exp. Hematol.33 (1): 62–72. doi:10.1016/j.exphem.2004.10.005. PMID15661399.
Sun NN, Fastje CD, Wong SS, et al. (2005). "Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line". Toxicology and industrial health19 (7–10): 157–63. doi:10.1191/0748233703th185oa. PMID15747776.